Search
Icecure Medical Ltd
ICCMAdd to Watchlist
5.490USD
+0.210+3.98%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
445.68MMarket Cap
LossP/E TTM
More Details of Icecure Medical Ltd Company
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Icecure Medical Ltd Info
Ticker SymbolICCM
Company nameIcecure Medical Ltd
IPO dateFeb 02, 2011
CEOShamir (Eyal)
Number of employees64
Security typeOrdinary Share
Fiscal year-endFeb 02
Address7 Ha'eshel St.
CityCAESAREA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code3079504
Phone97246230333
Websitehttps://icecure-medical.com/
Ticker SymbolICCM
IPO dateFeb 02, 2011
CEOShamir (Eyal)
Company Executives of Icecure Medical Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
28.72K
+31.49%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+50.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
14.80K
+20.02%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
6.80K
+31.16%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
External Director
External Director
--
--
Mr. Doron Birger
Mr. Doron Birger
Independent Director
Independent Director
--
--
Mr. Ron Abraham Mayron
Mr. Ron Abraham Mayron
Chairman of the Board
Chairman of the Board
--
--
Ms. Tlalit Bussi Tel-Tzure
Ms. Tlalit Bussi Tel-Tzure
Vice President - Business Development & Marketing
Vice President - Business Development & Marketing
--
--
Ms. Sharon Levita
Ms. Sharon Levita
External Director
External Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
28.72K
+31.49%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+50.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
14.80K
+20.02%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
6.80K
+31.16%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
External Director
External Director
--
--
FAQs
Who are the top five shareholders of Icecure Medical Ltd?
The top five shareholders of Icecure Medical Ltd are: Mr. Eyal Shamir
How many institutions hold shares of Icecure Medical Ltd (ICCM)?
As of 2026Q1, 32 institutions hold shares of Icecure Medical Ltd, with a combined market value of approximately 628.53K, accounting for 0.77% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 106962.00.